Indivior (INDV) Competitors

$22.39 -0.81 (-3.48%)

As of 11:26 AM Eastern

INDV vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Indivior stock or one of its competitors? The main competitors of Indivior include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Indivior vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Indivior (NASDAQ:INDV) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations, institutional ownership and media sentiment.

: Indivior has a consensus price target of $22.00, indicating a potential downside of 1.76%. Given Indivior's stronger consensus rating and higher probable upside, analysts clearly believe Indivior is more favorable than 180 Life Sciences.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Indivior
0 Sell rating(s)

0 Hold rating(s)

5 Buy rating(s)

1 Strong Buy rating(s)
3.17
: Indivior has a net margin of 6.65% compared to 180 Life Sciences' net margin of 0.00%. 180 Life Sciences' return on equity of 0.00% beat Indivior's return on equity.
Company Net Margins Return on Equity Return on Assets
180 Life Sciences N/A N/A N/A
Indivior 6.65% -86.28% 16.26%
: Indivior has higher revenue and earnings than 180 Life Sciences.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
180 Life Sciences N/A N/A N/A N/A N/A
Indivior $1.19B N/A $2M $0.62 36.12
: In the previous week, Indivior had 4 more articles in the media than 180 Life Sciences. MarketBeat recorded 4 mentions for Indivior and 0 mentions for 180 Life Sciences. Indivior's average media sentiment score of 0.48 beat 180 Life Sciences' score of 0.00 indicating that Indivior is being referred to more favorably in the news media.
Company Overall Sentiment
180 Life Sciences Neutral
Indivior Neutral
: 60.3% of Indivior shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
180 Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Indivior	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	3.17

Company	Net Margins	Return on Equity	Return on Assets
180 Life Sciences	N/A	N/A	N/A
Indivior	6.65%	-86.28%	16.26%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
180 Life Sciences	N/A	N/A	N/A	N/A	N/A
Indivior	$1.19B	N/A	$2M	$0.62	36.12

Company	Overall Sentiment
180 Life Sciences	Neutral
Indivior	Neutral

Summary

Indivior beats 180 Life Sciences on 10 of the 11 factors compared between the two stocks.

Get Indivior News Delivered to You Automatically

Subscribe Now

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INDV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INDV vs. The Competition

Export to Excel

Metric	Indivior	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$2.53B	$5.72B	$10.27B
Dividend Yield	N/A	57.22%	5.72%	4.60%
P/E Ratio	36.12	23.24	75.12	26.29
Price / Sales	N/A	530.18	512.85	173.43
Price / Cash	12.75	27.56	25.81	29.90
Price / Book	-8.89	5.37	13.64	6.29
Net Income	$2M	$32.95M	$3.28B	$270.21M
7 Day Performance	-9.19%	-0.15%	0.16%	1.79%
1 Month Performance	-4.55%	4.36%	4.61%	5.99%
1 Year Performance	134.73%	-2.63%	78.04%	27.88%

Indivior Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INDV Indivior	2.347 of 5 stars	$22.39 -3.5%	$22.00 -1.8%	+134.2%	$0.00	$1.19B	36.12	1,051
ATNFW 180 Life Sciences	N/A	$0.18 -7.1%	N/A	+1,107.9%	$0.00	N/A	0.00	7	Gap Up
LBPSW 4D pharma	N/A	N/A	N/A	N/A	$0.00	$522K	0.00	N/A
AEHAW Aesther Healthcare Acquisition	N/A	$0.00 flat	N/A	N/A	$0.00	N/A	0.00	2
AIMDW Ainos	N/A	$0.19 -7.2%	N/A	N/A	$0.00	$110.87K	0.00	40
ALVOW Alvotech	N/A	$1.17 +1.5%	N/A	N/A	$0.00	$560.10M	0.00	4	Gap Up
ARAV ARAVIVE	N/A	$0.04 flat	N/A	N/A	$0.00	$9.14M	0.00	20	High Trading Volume
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.03 flat	N/A	N/A	$0.00	N/A	0.00	15
BFRIW Biofrontera	N/A	$0.10 -26.4%	N/A	N/A	$0.00	$39.19M	0.00	70
BTMDW biote	N/A	$0.01 -10.5%	N/A	N/A	$0.00	$199.07M	0.00	N/A	Gap Down
BCTXW BriaCell Therapeutics	N/A	$0.03 +3.5%	N/A	-83.4%	$0.00	N/A	0.00	8	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:INDV) was last updated on 9/16/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Indivior (INDV) Competitors

INDV vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Indivior vs. Its Competitors

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INDV vs. The Competition

Indivior Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Indivior (INDV) Competitors

INDV vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Indivior vs. Its Competitors

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INDV vs. The Competition

Indivior Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools